Success Metrics

Active Trials
1(50%)

Phase Distribution

Ph phase_4
1
50%
Ph phase_3
1
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 31 (50.0%)
Phase 41 (50.0%)

Trials by Status

withdrawn150%
active_not_recruiting150%

Recent Activity

1 active trials
Showing 2 of 2
active_not_recruitingphase_4

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

NCT05099276
withdrawnphase_3

Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures

NCT05518279

Clinical Trials (2)

Showing 2 of 2 trials
NCT05099276Phase 4

Extended Postoperative Oral Tranexamic Acid in Knee Replacement

Active Not Recruiting
NCT05518279Phase 3

Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures

Withdrawn

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2